Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum.

Authors

Julie A. DeLoia, George Washington University
Nikhil R. Bhagwat, University of Pittsburgh
Kathleen M. Darcy, Roswell Park Cancer Institute, Buffalo, NY
Mary Strange, University of Pittsburgh
Chunquio Tian
Kevin Nuttall
Thomas C. Krivak, University of Pittsburgh
Laura J. Niedernhofer, University of Pittsburgh

Document Type

Journal Article

Publication Date

9-2012

Journal

Gynecologic Oncology

Volume

Volume 126, Issue 3

Inclusive Pages

448-454

Keywords

DNA-Binding Proteins--genetics; DNA-Binding Proteins--metabolism; Endonucleases--genetics; Endonucleases--metabolism; Neoplasms; Glandular and Epithelial--genetics; Neoplasms; Glandular and Epithelial--metabolism; Ovarian Neoplasms--genetics; Ovarian Neoplasms--metabolism; RNA; Messenger--metabolism

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Deloia, Julie A (09/2012). Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum. Gynecologic Oncology, 126(3), 448-454.

Peer Reviewed

1

Open Access

1